Lannett sees fall in Q1 sales
Lannett posted a net loss of $403.561 for the first quarter 2010, or $0.02 loss per diluted share, compared to net loss of $2.86m, or $0.11 per diluted
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Sage Bionetworks said that a team of network biologists, systems biologists, statistical geneticists and computational biologists use coherent datasets containing clinical, genetic and molecular layers of information to